Roberta Carpenito

Dr. Roberta Carpenito


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
DCDavide Charrier
Davide Charrier
Giuseppe CerulloGiuseppe Cerullo
Giuseppe Cerullo
RCRoberta Carpenito
Roberta Carpenito
VVVincenzo Vindigni
Vincenzo Vindigni
Franco BassettoFranco Bassetto
Franco Bassetto
Antonio PaoliAntonio Paoli
Antonio Paoli
Obesity is defined as a complex, systemic disease characterized by excessive and dysfunctional adipose tissue, leading to adverse health effects. This condition is marked by low-grade inflammation, oxidative stress, and metabolic abnormalities, including mitochondrial dysfunction. These factors promote energy dysregulation and impact body composition not only by increasing body fat but also by promoting skeletal muscle mass atrophy. The decline in muscle mass is associated with an increased risk of all-cause mortality in individuals with this disease. The European Food Safety Authority approved pyrroloquinoline quinone (PQQ), a natural compound, as a dietary supplement in 2018. This narrative review aims to provide a comprehensive overview of the potential role of PQQ, based on its anti-inflammatory and antioxidant properties, in addressing dysfunctional adipose tissue metabolism and related disorders.

17 July 2025 in Cancers
Verified
Journal Article
Open access
PDF file
Tito BrambulloTito Brambullo
Tito Brambullo
SLStefano L’erario
Stefano L’erario
FMFrancesco Marena
Francesco Marena
RCRoberta Carpenito
Roberta Carpenito
ACAlfio Luca Luca Costa
Alfio Luca Luca Costa
Franco BassettoFranco Bassetto
Franco Bassetto
Background/Objectives: The gold standard of treatment for both melanoma and non-melanoma skin cancers is wide surgical resection to obtain oncological radicality, which occasionally results in functional or aesthetic impairment, potentially affecting quality of life. Despite the increased complexity of the technique, extended duration of hospitalization, and prolonged surgical operative times, microsurgery can facilitate the reconstruction of locally invasive skin cancers following ablative surgery and may yield superior functional and aesthetic outcomes. Consequently, microsurgical reconstruction is more likely to be necessary if a large skin tumor requires excision. However, the impact of this extensive and complex procedure on patients with skin cancer has not yet been fully elucidated. The objective of this research was to critically analyze the utilization of free flap reconstruction subsequent to skin cancer therapy. Through a comprehensive examination of published data, this study aimed to assess the potential benefits and drawbacks associated with this reconstructive approach. Methods: A systematic review of studies that were published from January 2004 to May 2024 was conducted using the MEDLINE online database search. To present an evidence summary and provide a systematic approach and quality assessment, the GRADE® rating was applied to the results. Results: This review summarizes the oncological and clinical data, including previous interventions, adjuvant and neoadjuvant therapies, nodal status, distant metastasis, and follow-up time. Surgical outcome parameters such as healing time, flap survival, revision rate success, and minor and major complications were documented. Along with the findings, a quality assessment of the studies was also provided. Conclusions: This systematic review underscores the extensive use and efficacy of microsurgery for reconstruction after skin cancer excision; however, the literature remains limited by inconsistent reporting of oncological outcomes and the lack of a standardized approach to evaluate the impact of free flap reconstruction on both immediate and long-term cancer-specific results.

1 July 2024 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
Tito BrambulloTito Brambullo
Tito Brambullo
RCRoberta Carpenito
Roberta Carpenito
FRFederico Ricci
Federico Ricci
VVVincenzo Vindigni
Vincenzo Vindigni
FBFranco Bassetto
Franco Bassetto
Background: Currently, the evaluation of pigmented skin lesions relies on dermoscopy, which has become the standard of care. As melanoma is one of the principal areas of expertise in plastic surgery, it is essential that diagnostic skills be acquired during the course of specialization. This study aimed to assess the impact and effectiveness of a brief and intensive dermoscopy training program for plastic surgery residents. Methods: This study was carried out on a group of 41 doctors, who were divided into three categories based on their experience in dermoscopy (none, intermediate, and advanced). A preliminary assessment of each participant’s baseline knowledge was conducted by using a 15-query test. Subsequently, the participants attended a 90-minute lecture on diagnostic techniques and the process of differentiating between various skin lesions. To determine the effectiveness of the lecture in improving diagnostic skills, the participants were tested immediately after the lecture and again after a 3-month period. Results: At the conclusion of the final examination, all three groups achieved an accuracy rate of at least 80% for dermatoscopic diagnosis. However, none of the groups was completely successful. The variations in diagnostic accuracy among the three groups are presented, and P values were calculated for each group. Conclusion: The short, intensive course of dermoscopy has proven to have a significant positive impact on plastic surgeons in their postdegree training program.

1 November 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
ACAlfio Luca Luca Costa
Alfio Luca Luca Costa
Barbara ZavanBarbara Zavan
Barbara Zavan
GFGloria Fanton
Gloria Fanton
RCRoberta Carpenito
Roberta Carpenito
VVVincenzo Vindigni
Vincenzo Vindigni
Franco BassettoFranco Bassetto
Franco Bassetto
Background: Chronic diabetic cutaneous wounds are sustained by persistent inflammation, impaired angiogenesis, and oxidative stress, with delayed healing. Adipose-derived stem cell extracellular vesicles (ADSC-EVs) act as paracrine mediators and are candidate regenerative therapies. This systematic review synthesized controlled in vivo evidence on ADSC-EVs in diabetic cutaneous wound healing. Methods: PubMed, Embase, Scopus, and Cochrane Library were searched for controlled in vivo studies (publication window 2015 to July 2025; last search 22 October 2026) evaluating ADSC-EVs in diabetic cutaneous wound models. The review followed PRISMA 2020 and was registered in PROSPERO. Methodological quality and reporting were assessed with SYRCLE and CAMARADES. Owing to heterogeneity in models, EV preparation, dosing, delivery, and outcome reporting, the findings were synthesized descriptively. The primary outcome was quantitative macroscopic wound closure, reported as printed numerical values or as planimetric wound-closure trajectories. Results: Nineteen controlled studies met inclusion criteria; all used diabetic rodent wound models. ADSC-EVs were directionally associated with faster wound closure versus vehicle or scaffold-only controls. In six within-study comparisons, hypoxia-preconditioned, circRNA-enriched, or miRNA-enriched vesicles reported greater wound closure than native EVs. Biomaterial carriers were associated with greater closure than free EVs in five studies. The direction of effect was consistent across streptozotocin, high-fat diet plus streptozotocin and db/db models, and across doses of 1 to 200 µg per application, but no study compared models or doses directly. Secondary outcomes included collagen organization, inflammatory markers, and macrophage phenotype. Blinded outcome assessment was reported in one study, and no study reported a sample-size calculation. Conclusions: In preclinical diabetic wound models, ADSC-EVs were consistently associated with enhanced healing across macroscopic and histological endpoints. Heterogeneous reporting and limited blinding preclude effect size estimation. Clinical efficacy, optimal dose, and delivery strategy remain to be established.